Loading...

Table of Content

    30 June 2020, Volume 1 Issue 3
    Contents
    2020, 1(3):  0-0. 
    Asbtract ( 296 )   PDF (479KB) ( 323 )  
    Related Articles | Metrics
    Invited Review
    Recent research progress in the design and construction of synthetic microbial consortia
    Xiujuan QIAN, Lin CHEN, Wenming ZHANG, Jie ZHOU, Weiliang DONG, Fengxue XIN, Min JIANG
    2020, 1(3):  267-284.  doi:10.12211/2096-8280.2020-040
    Asbtract ( 1643 )   HTML ( 179)   PDF (2692KB) ( 1954 )  
    References | Related Articles | Metrics

    Synthetic biology is developed from designing and building simple elements and modules to de novo buildup complex metabolic pathway and network. Recent advances in microbial consortia present a valuable approach for expanding the scope of synthetic biology. First, microbial consortia can create a novel microenvironment for strains, potentially resulting in the activation of silent metabolic pathways which are not expressed under "normal" cultivation conditions, leading to discovery of novel chemicals for novel drugs and other purposes; Second, microbial consortia allow a labor division for metabolic modules among different microbial strains, which permit improved efficiency and more complex behavior than monocultures; Third, microbial consortia consist of multiple functional microorganisms, allowing capability for utilizing complex substrate with robust tolerance to environmental stresses. All these endow microbial consortia an indispensible role in the areas of medicine, food, chemical engineering, energy industry and biodegradation for environmental pollutants. However, the study of synthetic microbial consortia is still in its infancy, facing many unknowns and challenges in the construction of stable and controllable microbial consortia systems, intercellular communication and regulation of microbial population structure. This review summarizes the application of synthetic microbial consortia in the areas of human health monitoring and medicine exploitation, synthesis of valuable compounds, consolidated bioprocessing of lignocellulosic materials and environmental bioremediation, as well as the construction principles and research methods for microbial consortia study. In addition, the unrevealed interaction mechanism underlying microbial consortia is addressed. Moreover, the outstanding challenges and future directions to advance the development of high-efficient, stable and controllable synthetic microbial consortia are highlighted.

    ePlant: scientific connotations, bottlenecks, and development strategies
    Xinguang ZHU, Tiangen CHANG, Qingfeng SONG, Shuoqi CHANG, Chongrong WANG, Guoqing ZHANG, Ya GUO, Shaochuan ZHOU
    2020, 1(3):  285-297.  doi:10.12211/2096-8280.2020-018
    Asbtract ( 901 )   HTML ( 47)   PDF (2450KB) ( 847 )  
    References | Related Articles | Metrics

    Plant systems and synthetic biology has gained more and more attention in recent years as a result of the rapid advances in genomics, proteomics, metabolomics, epigenomics and genome editing technologies. Plant systems and synthetic biology for quantitative studies of plant systems differs from traditional plant science that mainly focuses on descriptive and qualitative studies of plant systems. In addition, plant systems and synthetic biology also emphasizes the design and creation of new biochemical pathways, regulatory circuits, signaling pathways, and even biological structures that are not exist in native plants hosts for desired properties.

    A number of mega projects in plant synthetic biology have been initiated in recent years, all with a common goal of boosting crop yield and developing technologies for Green Revolution of agriculture. With these projects, it was evident that to maximize the benefit of plant synthetic biology, we ought to develop a robust system model for plant growth and development: ePlant, which includes the simulation not only for molecular, biochemical, physiological, and physical processes in different organs of a plant, but also for interaction between plant and environment as highlighted by the system of soil, root, plant and air. The ePlant model needs to be developed using a divide-and-conquer approach followed by the modular construction, and once developed, it can be used as a major tool for basic research in plant science, studies for interaction among genes, environment and management practices, identification of new options to engineer crops for desired properties, and finally design of ideotypes desired for crop breeding.

    To expedite the development of ePlant model, we propose a number of priorities and strategies, which include developing basic models for plant growth and development, collecting systems data related to partitioning of similarities among different organs, creating new methods to integrate modules at different temporal and spatial scales, building up public online platforms to support the development of ePlant, developing algorithms to support effective integration of ePlant models with phenomics data, and finally forming policies to nurture the development of communities on plant systems modeling.

    We emphasize a strong demand for an online platform or portal to support the development of ePlant models and their applications. This platform needs to include not only the basic models, data supporting model development and application and high-performance super-computing resources to enable the models' widely applications by the plant science research community. We also advocate for using rice as the model species to construct such an ePlant, considering the large quantities of studies on rice genomics, genetics, physiology, breeding and agronomics, which will expedite the development, validation and application of ePlant models. After ePlant model developed for rice (eRice), we can use it to guide dissection of mechanism underlying high yield formation in current rice lines, to design ideotypes for super-high-yield rice breeding, and to format optimal agronomic practices.

    Self-assembly, biosynthesis, functionalization and applications of virus-based nanomaterials
    Wenjing ZHANG, Ming LI, Wei ZHOU, Xian-en ZHANG, Feng LI
    2020, 1(3):  298-318.  doi:10.12211/2096-8280.2020-031
    Asbtract ( 984 )   HTML ( 73)   PDF (3858KB) ( 1320 )  
    Figures and Tables | References | Related Articles | Metrics

    Viruses are conventionally known as infectious pathogens. Meanwhile, they are ordered assemblies of biomacromolecules with proteins and nucleic acids as major components, and typically at nanoscale dimensions ranging from tens to hundreds of nanometers. Recently, viruses have received extensive interest in multidisciplinary studies, especially in the field of materials. From the viewpoint of materials science, viral capsids have several beneficial characteristics such as uniform shape and size, structural addressability, convenient modification, fast production through biosynthesis, and good biocompatibility. These features make virus-based materials particularly useful in many scenarios. In this review, firstly we introduce the structural characteristics of viruses and virus-based nanomaterials. Secondly, we describe the strategies for self-assembly, biosynthesis and functionalization of virus-based nanomaterials, including genetic engineering, chemical modifications, biomineralization and self-assembly. Thirdly, we discuss the applications of virus-based nanomaterials in diverse fields such as biomedical imaging, biosensing, tissue engineering, nanoreactors, microelectronics, nanophotonics, and deliveries of genes, drugs, vaccines and immunomodulators. Virus-based nanomaterials are particularly suitable for carrying immunomodulators and vaccines because of their surface pathogen-related molecular patterns. However, the immune response and clearance of virus-based nanomaterials are disadvantageous for in vivo imaging and drug delivery. The development of "immune stealth" modification strategies has shielded the immunogenicity of virus-based nanomaterials to some extent, which is conducive to improving the targeted delivery efficiency of virus-based nanomaterials. Imaging-aided exploration of in vivo behaviors with virus-based nanomaterials would be helpful for the design and re-design of this kind of materials to meet the requirement of clinical applications, which depends on the development of new imaging probes and methods. In addition, the applications of virus-based nanomaterials in the fields of tissue engineering, microelectronics, nanoreactors, and nanophotonics have specific requirements for structure stability and dynamic control of virus-based nanomaterials. The design, manipulation, and functionalization of virus-based nanomaterials would benefit deeper understanding of the structure and assembly of viruses, development of rational design techniques for self-assembling protein materials and high-throughput synthetic biology methods, paving the way for the practical applications of virus-based nanomaterials.

    Scalable mining of proteins for biocatalysis via synthetic biology
    Jianzhi ZHANG, Lihao FU, Ting TANG, Songya ZHANG, Jing ZHU, Tuo LI, Zining WANG, Tong SI
    2020, 1(3):  319-336.  doi:10.12211/2096-8280.2020-028
    Asbtract ( 2946 )   HTML ( 270)   PDF (2526KB) ( 3276 )  
    References | Related Articles | Metrics

    Biomanufacturing provides a sustainable alternative to traditional petrochemical processes in producing chemicals, drugs, and functional materials. Enzymes are cores for creating catalytic biosystems with diverse functions. Due to the lack of predictive models for enzyme functions, however, rational design is still challenging. On the other hand, next-generation sequencing reveals millions of diverse natural enzymes, of which only a tiny fraction have been experimentally characterized. Synthetic biology applies engineering principles to study, engineer, and create biological systems. Through standardization and modularization, synthetic biology enables large-scale prototyping of enzyme sequences, which not only helps to identify efficient biocatalytic parts, but also accelerates quantitative understanding of sequence-structure-function relationship. Here we review recent advances in scalable mining of enzymes via synthetic biology. We firstly introduce computational tools for functional clustering and prioritization of promising sequences from enormous genome/protein databases, followed by experimental approaches for high-throughput cloning, expression, and characterization of selected candidates. We then discuss the applications of such tools in systematic studies of enzyme (super) families. We conclude with future perspectives in creating integrated synthetic biology foundries to accelerate enzyme mining.

    Recent advances in the production of phenylpropanoic acids and their derivatives by genetically engineered microorganisms
    Fuxing NIU, Yunping DU, Yuanbin HUANG, Hetian ZHOU, Jianzhong LIU
    2020, 1(3):  337-357.  doi:10.12211/2096-8280.2020-014
    Asbtract ( 1513 )   HTML ( 107)   PDF (2280KB) ( 2273 )  
    References | Related Articles | Metrics

    Phenylpropanoic acids are important phenylpropanoid compounds, which are natural organic acids containing the C6-C3 unit, including phenylacrylic acid and phenyllactic acid compounds. Many phenylpropanoic acids have activities in antioxidation, antibacteria, antitumors, antivirus, anti-inflammation, immunity enhancement, reducing blood lipids, and treating cardiovascular diseases. Phenylpropanoic acids are widely used in food, medicine, flavor, cosmetics, agriculture, and so forth. In plants, phenylpropanoids are synthesized from L-phenylalanine or L-tyrosine derived from the shikimate pathway. To overcome the drawbacks of their extract from plants, biotechnological production is a good alternative. With advances in metabolic engineering and synthetic biology, many microorganisms have been engineered to produce phenylpropanoic acids and their derivatives. Herein, we systematically and comprehensively review recent advancements in the production of phenylpropanoic acids and their derivatives by metabolic engineered microorganisms. These compounds include cinnamic acid, styrene, p-coumaric acid, p-hydroxystyrene, p-coumaroyl shikimate, caffeic acid, chlorogenic acid, 3,4-hydroxystyrene, ferulic acid, curcumin, L-DOPA, phenyllactic acid, p-hydroxyphenyllactic acid, salvianic acid A, and rosmarinic acid. Then, some main synthetic biology strategies for the microbial production of the aromatics are summarized. Finally, future perspectives about engineering microorganisms for producing phenylpropanoids are discussed. Some strategies are proposed: 1) tolerance engineering using biosensor-based adaptive laboratory evolution; 2) oxidative engineering; 3) modular coculture engineering; 4) systems metabolic engineering.

    Applications of synthetic biology in the production of fluorinated compounds
    Gaoli WANG, Xuerui JIN, Yunzi LUO
    2020, 1(3):  358-371.  doi:10.12211/2096-8280.2020-003
    Asbtract ( 1359 )   HTML ( 83)   PDF (2666KB) ( 1501 )  
    Figures and Tables | References | Related Articles | Metrics

    Fluorine is the most abundant halogen on the earth. However, the electronegativity of fluorine is extremely strong, which makes the availability of natural fluorine-containing compounds very limited. The introduction of fluorine into organic molecules endows them with new functions and better physicochemical properties, which attracts many synthetic chemists. Since the highly polarized C—F bond is difficult to break, the introduction of fluorine into drug molecules can improve their chemical properties, and thus enhance their metabolic stability for good affinity with target proteins. Nevertheless, it is often difficult to synthesize fluoride compounds with high selectivity by chemical methods. In recent years, the development of synthetic biology has provided new opportunities for the production of fluoride compounds. For example, the natural fluorinase discovered from Streptomyces and its optimized mutants can achieve the formation of C—F bonds. This strategy focuses on using synthetic biology strategies to mine and activate silent gene clusters that synthesize potential fluorinated products, as well as using protein engineering technology to design efficient fluorinase through rational design or directed evolution. On the other hand, the introduction of fluorine-containing building blocks into the natural product biosynthetic pathway can successfully synthesize new fluorinated products. This approach starts with simple fluorinated compounds in the synthesis of fluorine-containing building blocks, and then fluorine can be selectively introduced into biosynthetic pathways for complicated products such as polyketides to form fluorinated natural products. This review summarizes the strategies developed for the production of fluorinated compounds using fluorinase and fluoride biosynthesis systems, and discusses the important applications of synthetic biology methods in the production of fluorinated compounds. We prospect that with the development of synthetic biology techniques, high-efficiency biosynthesis of fluorine-containing products will be achieved, and thus the synthesis of complex chiral fluorinated compounds is expected to be addressed.

    Analysis of global patents for the trend of synthetic biology inventions
    Daming CHEN, Guangming ZHOU, Xiao LIU, Yuelei FAN, Yue WANG, Kaiyun MAO, Xuebo ZHANG, Yan XIONG
    2020, 1(3):  372-384.  doi:10.12211/2096-8280.2020-035
    Asbtract ( 2680 )   HTML ( 293)   PDF (2356KB) ( 2805 )  
    Figures and Tables | References | Related Articles | Metrics

    Synthetic biology is an emerging interdisciplinary field which combines the principles of engineering and biology, aiming at the (re-) design, modification and fabrication of new and existing biological systems. The techniques developed by synthetic biology are revolutionizing biotechnology and the pharmaceutical industry. From the perspective of patent analysis, this article reviews the technological history of synthetic biology and its applications. The development of synthetic biology techniques can be divided into four stages. 1) The first stage before 2005, is represented by the application of gene regulatory circuits in the field of metabolic engineering, and large-scale production of artemisinin precursor in E.coli was achieved. 2) During the second stage from 2005 to 2011, basic research on improving engineered natural and artificial cells was developed rapidly, however the number of patent applications did not increase significantly, but new tools and methods continued to accumulate, reflecting the early development characteristics of "engineering biology". 3) In the third stage from 2011 to 2015, with the development of novel genome editing, as well as the incorporation of those fundamentals into synthetic biology tools, patent application was doubled. 4) At the fourth stage since 2015, the design-build-test (DBT) cycle of synthetic biology has been extended to the design-build-test-learn (DBTL) cycle, therefore enabling broader convergence and interoperability of semiconductor synthetic biology, engineering biology and other emerging frontiers. After going through the above four development stages, a number of synthetic biology companies have grown up, and many traditional pharmaceutical companies have also invested in the field of synthetic biology for drug development, generating a variety of patents related to gene synthesis, gene therapy, cell therapy, biological materials, genome editing, et al. Through the analysis of representative synthetic biology enterprises' product development and their corresponding patent layout, we highlight the main technical modules and application fields of synthetic biology technologies. Based on the systematic analysis of these key technologies and patents, we develope a break-up and comprehensive analysis framework to clarify the characteristics of synthetic biology for competitive landscapes and predict their technological trends. Especially, we developed a synthetic biology knowledge map to systematically present a landscape for synthetic biology development. By translating patent information into competitive intelligence, this study also investigated the impact of synthetic biology applications on various aspects of industry and society. Finally, this article summarizes and speculates the development of synthetic biology, including the development of enabling technology platforms and tools, definition and use of standard essential patents (SEPs), and relationship between intellectual property management and product accessment.

    Grant and funding for synthetic biology at NSFC from 2010 to 2019
    Quansheng DU, Wei HONG, Yan ZU
    2020, 1(3):  385-394.  doi:10.12211/2096-8280.2020-065
    Asbtract ( 1595 )   HTML ( 163)   PDF (1572KB) ( 1826 )  
    Figures and Tables | References | Related Articles | Metrics

    Synthetic biology is a cutting-edge research field in life science with engineering concepts, targeted design, transformation and even re-construction of organisms. The technical methods and tools of synthetic biology may break through limit of natural evolution for life. It expands the understanding of life phenomena and laws through novel ideas, which is expected to lead the future of life science research. Chinese scientists have made a series of innovative achievements in the frontiers of chromosome synthesis, genetic element buildup, and minimal genome construction with the support of the National Science Foundation of China (NSFC). This article summarizes the application and funding status of synthetic biology projects from 2010 to 2019 based on the NSFC Network Information System database, as well as,the main research progress and international synthetic biology development planning and layout. Accordingly, it analyzes the challenges in funding synthetic biology research by NSFC, and suggests the management of synthetic biology projects, which provides reference for relevant researchers.